Waheed Nadia, Chief Medical Officer of Ocular Therapeutix, Inc. ($OCUL), sold shares on the open market three times in the last year for a total of about $210,000. Her most recent OCUL insider sale occurred on February 20, 2026. These open market sales rank 8,319th among 11,678 individual insiders, well below the average of 8.6 million per insider across about 6.4 transactions. Waheed Nadia made no open market purchases in the period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 20, 2026 | OCULAR THERAPEUTIX, INC | $OCUL | Waheed Nadia | Chief Medical Officer | S | Common Stock | 3510 | $7.74 | 314,907.0000 | 187,241,483 | 1.10% | 0.00% |
| Feb. 12, 2026 | OCULAR THERAPEUTIX, INC | $OCUL | Waheed Nadia | Chief Medical Officer | S | Common Stock | 7863 | $9.04 | 318,417.0000 | 187,241,483 | 2.41% | 0.00% |
| Jan. 2, 2026 | OCULAR THERAPEUTIX, INC | $OCUL | Waheed Nadia | Chief Medical Officer | A | Stock Option (Right to Buy) | 240932 | $0.00 | 240,932.0000 | 187,241,483 | 9999.99% | 0.13% |
| Jan. 2, 2026 | OCULAR THERAPEUTIX, INC | $OCUL | Waheed Nadia | Chief Medical Officer | A | Common Stock | 79112 | $0.00 | 326,280.0000 | 187,241,483 | 32.01% | 0.04% |
| Aug. 12, 2025 | OCULAR THERAPEUTIX, INC | $OCUL | Waheed Nadia | Chief Medical Officer | A | Common Stock | 40363 | $0.00 | 247,168.0000 | 172,594,662 | 19.52% | 0.02% |
| Aug. 12, 2025 | OCULAR THERAPEUTIX, INC | $OCUL | Waheed Nadia | Chief Medical Officer | A | Stock Option (Right to Buy) | 122923 | $0.00 | 122,923.0000 | 172,594,662 | 9999.99% | 0.07% |
| June 2, 2025 | OCULAR THERAPEUTIX, INC | $OCUL | Waheed Nadia | Chief Medical Officer | S | Common Stock | 13861 | $8.05 | 206,805.0000 | 169,396,989 | 6.28% | 0.01% |
| Feb. 11, 2025 | OCULAR THERAPEUTIX, INC | $OCUL | Waheed Nadia | Chief Medical Officer | A | Stock Option (Right to Buy) | 237000 | $0.00 | 237,000.0000 | 158,265,162 | 9999.99% | 0.15% |
| Feb. 11, 2025 | OCULAR THERAPEUTIX, INC | $OCUL | Waheed Nadia | Chief Medical Officer | A | Common Stock | 79000 | $0.00 | 220,666.0000 | 158,265,162 | 55.76% | 0.05% |
| June 1, 2024 | OCULAR THERAPEUTIX, INC | $OCUL | Waheed Nadia | Chief Medical Officer | A | Stock Option (Right to Buy) | 425000 | $0.00 | 425,000.0000 | 132,021,945 | 9999.99% | 0.32% |
| June 1, 2024 | OCULAR THERAPEUTIX, INC | $OCUL | Waheed Nadia | Chief Medical Officer | A | Common Stock | 141666 | $0.00 | 141,666.0000 | 132,021,945 | 9999.99% | 0.11% |